» Articles » PMID: 22961344

GATA5 Loss-of-function Mutation Responsible for the Congenital Ventriculoseptal Defect

Overview
Journal Pediatr Cardiol
Date 2012 Sep 11
PMID 22961344
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The ventriculoseptal defect (VSD) is the most common form of congenital heart disease and a leading noninfectious cause of infant mortality. Growing evidence demonstrates that genetic defects are associated with congenital VSD. Nevertheless, VSD is genetically heterogeneous, and the molecular basis for VSD in an overwhelming majority of patients remains unknown. In this study, the whole coding region of GATA5, a gene encoding a zinc finger transcription factor crucial for normal cardiogenesis, was sequenced in 120 unrelated patients with VSD. The available relatives of the patient harboring the identified mutation and 200 unrelated individuals used as controls were subsequently genotyped. The causative potential of a sequence variation was evaluated by MutationTaster, and the functional effect of the mutation was characterized using a luciferase reporter assay system. As a result, a novel heterozygous GATA5 mutation, p.L199V, was identified in a patient with VSD, which was absent in 400 control chromosomes. Genetic analysis of the mutation carrier's available family members showed that the substitution co-segregated with VSD transmitted in an autosomal dominant pattern. The p.L199V variation was automatically predicted to be disease causing, and the functional analysis showed that the GATA5 p.L199V mutant protein was associated with significantly reduced transcriptional activation compared with its wild-type counterpart. To the best of the authors' knowledge, this is the first report on the link of functionally compromised GATA5 to human VSD, suggesting potential implications for the early prophylaxis and personalized treatment of VSD.

Citing Articles

Whole-Exome Sequencing Identifies Novel GATA5/6 Variants in Right-Sided Congenital Heart Defects.

Zodanu G, Hwang J, Mudery J, Sisniega C, Kang X, Wang L Int J Mol Sci. 2025; 26(5).

PMID: 40076735 PMC: 11901071. DOI: 10.3390/ijms26052115.


Undetected Neuromuscular Disease in Patients after Heart Transplantation.

Bekele B, Gazzerro E, Schoenrath F, Falk V, Rost S, Hoerning S Int J Mol Sci. 2024; 25(14).

PMID: 39063061 PMC: 11277526. DOI: 10.3390/ijms25147819.


Genetic and epigenetic mechanisms in the development of congenital heart diseases.

Wu Y, Jin X, Zhang Y, Zheng J, Yang R World J Pediatr Surg. 2022; 4(2):e000196.

PMID: 36474778 PMC: 9648586. DOI: 10.1136/wjps-2020-000196.


Single-Nucleotide Polymorphisms in Exonic and Promoter Regions of Transcription Factors of Second Heart Field Associated with Sporadic Congenital Cardiac Anomalies.

Wang E, Fan X, Nie Y, Zheng Z, Hu S Balkan J Med Genet. 2022; 24(2):39-47.

PMID: 36249516 PMC: 9524169. DOI: 10.2478/bjmg-2021-0028.


A Combined Human and CRISPR/Cas9-Mediated Zebrafish Based Approach to Provide Phenotypic Data for Supporting Early Target Validation.

Winter M, Ono Y, Ball J, Walentinsson A, Michaelsson E, Tochwin A Front Pharmacol. 2022; 13:827686.

PMID: 35548346 PMC: 9082939. DOI: 10.3389/fphar.2022.827686.


References
1.
Salazar M, Consoli F, Villegas V, Caicedo V, Maddaloni V, Daniele P . Search of somatic GATA4 and NKX2.5 gene mutations in sporadic septal heart defects. Eur J Med Genet. 2011; 54(3):306-9. DOI: 10.1016/j.ejmg.2011.01.004. View

2.
Kasahara H, Lee B, Schott J, Benson D, Seidman J, Seidman C . Loss of function and inhibitory effects of human CSX/NKX2.5 homeoprotein mutations associated with congenital heart disease. J Clin Invest. 2000; 106(2):299-308. PMC: 314312. DOI: 10.1172/JCI9860. View

3.
Payne A, Chang S, Koenig S, Zinn A, Garg V . Submicroscopic chromosomal copy number variations identified in children with hypoplastic left heart syndrome. Pediatr Cardiol. 2012; 33(5):757-63. DOI: 10.1007/s00246-012-0208-9. View

4.
Yang Y, Wang J, Wang X, Wang Q, Tan H, Zhang M . Mutational spectrum of the GATA5 gene associated with familial atrial fibrillation. Int J Cardiol. 2012; 157(2):305-7. DOI: 10.1016/j.ijcard.2012.03.132. View

5.
Kodo K, Nishizawa T, Furutani M, Arai S, Yamamura E, Joo K . GATA6 mutations cause human cardiac outflow tract defects by disrupting semaphorin-plexin signaling. Proc Natl Acad Sci U S A. 2009; 106(33):13933-8. PMC: 2728998. DOI: 10.1073/pnas.0904744106. View